TY - JOUR
T1 - Uremic bone disease
T2 - Current knowledge, controversial issues, and new horizons
AU - Malluche, H. H.
AU - Monier-Faugere, M. C.
PY - 1991
Y1 - 1991
N2 - Abnormalities in mineral and bone metabolism occur early in the course of renal failure and uremic bone disease is a major contributing factor to the morbidity of patients with end-stage renal failure. In addition, new therapeutic approaches have generated new outlooks, problems and controversies. This article reviews our current accepted knowledge, the present numerous controversies, unresolved questions, new issues and new horizons.
AB - Abnormalities in mineral and bone metabolism occur early in the course of renal failure and uremic bone disease is a major contributing factor to the morbidity of patients with end-stage renal failure. In addition, new therapeutic approaches have generated new outlooks, problems and controversies. This article reviews our current accepted knowledge, the present numerous controversies, unresolved questions, new issues and new horizons.
UR - http://www.scopus.com/inward/record.url?scp=0026324421&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026324421&partnerID=8YFLogxK
M3 - Review article
C2 - 1813791
AN - SCOPUS:0026324421
SN - 0378-0392
VL - 17
SP - 281
EP - 296
JO - Mineral and Electrolyte Metabolism
JF - Mineral and Electrolyte Metabolism
IS - 4
ER -
